Regulatory Affairs Professionals Society

Recon: FDA denies Hengrui-Elevar liver cancer drug for the third time; GSK to pursue FDA nod for Jemperli for rectal cancer

Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
Regulatory Affairs Professionals Society

Asia-Pacific Roundup: India cuts prices of more than 30 drugs and biologics

India’s National Pharmaceutical Pricing Authority (NPPA) has announced price reductions for more than 30 drugs and biological ...
RAPS

Enterprise Membership

Develop your team. Strengthen performance. Drive regulatory excellence. RAPS Enterprise Memberships help organizations and companies invest in their people through scalable access to education, ...
RAPS

Chapters and Local Networking Groups (LNGs)

Fostering local and regional connections that strengthen careers and build lasting relationships. RAPS Chapters and Local Networking Groups (LNGs) bring together RAPS members and regulatory ...